Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility-Reference-Cited by-同舟云学术

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility

Published:2017-03-20 Issue:3 Volume:6 Page:e45
ISSN:1929-0748
Container-title:JMIR Research Protocols
language:en
Short-container-title:JMIR Res Protoc

Author:

Li Bin^ORCID,Eschrich Steven A^ORCID,Berglund Anders^ORCID,Mitchell Melissa^ORCID,Fenstermacher David^ORCID,Danaee Hadi^ORCID,Dai Hongyue^ORCID,Sullivan Daniel^ORCID,Trepicchio William L^ORCID,Dalton William S^ORCID

Publisher

JMIR Publications Inc.

Subject

General Medicine

Reference45 articles.

1. Targeted antitumour therapy – future perspectives

2. Integration of cancer genomics with treatment selection

3. Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009

4. Designing Transformative Clinical Trials in the Cancer Genome Era

5. A Sense of Urgency: Evaluating the Link between Clinical Trial Development Time and the Accrual Performance of Cancer Therapy Evaluation Program (NCI-CTEP) Sponsored Studies

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cohort Identification for Translational Bioinformatics Studies;Methods in Molecular Biology;2020-09-15

2. Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis;American Journal of Surgical Pathology;2019-09-26

3. Lack of expression of ALK and CD30 in breast carcinoma by immunohistochemistry irrespective of tumor characteristics;Medicine;2019-08

4. A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors;Investigational New Drugs;2019-04-16

5. Clinical Decision Support Tools Improving Cancer Care;Seminars in Oncology Nursing;2018-05